N-tert-Butoxycarbonyl DesMethyl Levofloxacin Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Yellow Solid

Verwenden

Protected Levofloxacin metabolite.

N-tert-Butoxycarbonyl DesMethyl Levofloxacin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-tert-Butoxycarbonyl DesMethyl Levofloxacin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
J & K SCIENTIFIC LTD.	18210857532; 18210857532	jkinfo@jkchemical.com	China	96815	76
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8065	58
XinYao(Shenzhen) Biological Technology Co., Ltd.	0755-89880280	3004662104@qq.com	China	1829	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57422	58
Energy Chemical	021-58432009 400-005-6266	marketing1@energy-chemical.com	China	45000	58
Guangzhou Austine Biotechnology Co., LTD	15918640830 13268843209	1947181658@qq.com	China	9028	58
Santa Cruz Biotechnology Inc	--	scbt@scbt.com	China	6594	58

---

• N-tert-Butoxycarbonyl DesMethyl Levofloxacin
• (3S)-10-[4-[(1,1-DiMethylethoxy)carbonyl]-1-piperazinyl]-9-fluoro-2,3-dih
• (3S)-N-tert-Butoxycarbonyl-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
• Levofloacin Impurity M
• 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 10-[4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
• Nitroxoline Impurity 11
• 1330277-19-4
• C22H26FN3O6
• Chiral Reagents, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
• Chiral Reagents
• Intermediates & Fine Chemicals
• Metabolites & Impurities
• Pharmaceuticals